| Primary |
| Product Used For Unknown Indication |
25.8% |
| Convulsion |
18.1% |
| Bipolar Disorder |
10.6% |
| Drug Use For Unknown Indication |
10.4% |
| Epilepsy |
8.5% |
| Bipolar I Disorder |
3.9% |
| Drug Exposure During Pregnancy |
2.3% |
| Schizophrenia |
2.3% |
| Mania |
2.1% |
| Psychotic Disorder |
2.0% |
| Schizoaffective Disorder Bipolar Type |
2.0% |
| Affective Disorder |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Bipolar Ii Disorder |
1.6% |
| Post-traumatic Stress Disorder |
1.5% |
| Grand Mal Convulsion |
1.3% |
| Depression |
1.1% |
| Hypertension |
1.1% |
| Migraine |
1.0% |
| Hypothyroidism |
0.8% |
|
| Product Substitution Issue |
22.8% |
| Therapeutic Response Unexpected With Drug Substitution |
7.8% |
| Convulsion |
6.8% |
| Tremor |
6.8% |
| Somnolence |
5.5% |
| Vomiting |
5.0% |
| Weight Increased |
4.6% |
| Drug Interaction |
4.1% |
| Platelet Count Decreased |
4.1% |
| Sedation |
4.1% |
| Thrombocytopenia |
4.1% |
| Pancreatitis |
3.7% |
| Product Quality Issue |
3.2% |
| Condition Aggravated |
2.7% |
| Drug Ineffective |
2.7% |
| Mental Status Changes |
2.7% |
| Ammonia Increased |
2.3% |
| Confusional State |
2.3% |
| Hyperammonaemia |
2.3% |
| Hyponatraemia |
2.3% |
|
| Secondary |
| Convulsion |
17.1% |
| Product Used For Unknown Indication |
15.7% |
| Bipolar Disorder |
11.8% |
| Hypertension |
7.6% |
| Bipolar I Disorder |
6.6% |
| Epilepsy |
5.8% |
| Drug Use For Unknown Indication |
4.8% |
| Anxiety |
3.7% |
| Psychotic Disorder |
3.4% |
| Agitation |
2.8% |
| Mania |
2.7% |
| Grand Mal Convulsion |
2.5% |
| Abnormal Behaviour |
2.2% |
| Diabetes Mellitus |
2.2% |
| Hyperlipidaemia |
2.1% |
| Blood Cholesterol Increased |
2.0% |
| Migraine |
1.8% |
| Hypothyroidism |
1.7% |
| Insomnia |
1.7% |
| Schizoaffective Disorder |
1.7% |
|
| Tremor |
13.5% |
| Weight Increased |
12.0% |
| Convulsion |
8.3% |
| Grand Mal Convulsion |
6.8% |
| Tardive Dyskinesia |
6.0% |
| Suicide Attempt |
5.3% |
| Vision Blurred |
5.3% |
| Suicidal Ideation |
4.5% |
| Drug Ineffective |
3.8% |
| Hyperammonaemic Encephalopathy |
3.8% |
| Treatment Noncompliance |
3.8% |
| Condition Aggravated |
3.0% |
| Granulocytopenia |
3.0% |
| Iron Overload |
3.0% |
| Mania |
3.0% |
| Product Substitution Issue |
3.0% |
| Psychotic Disorder |
3.0% |
| Somnolence |
3.0% |
| Unresponsive To Stimuli |
3.0% |
| Vomiting |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.7% |
| Bipolar Disorder |
10.7% |
| Drug Use For Unknown Indication |
10.2% |
| Depression |
7.3% |
| Schizophrenia |
5.0% |
| Hypertension |
4.6% |
| Pain |
4.5% |
| Convulsion |
4.3% |
| Epilepsy |
4.3% |
| Schizoaffective Disorder |
4.0% |
| Anxiety |
3.4% |
| Insomnia |
3.1% |
| Sleep Disorder |
2.7% |
| Affective Disorder |
2.2% |
| Fibromyalgia |
1.7% |
| Psychotic Disorder |
1.7% |
| Diabetes Mellitus |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Migraine |
1.6% |
| Rheumatoid Arthritis |
1.6% |
|
| Granulocytopenia |
13.3% |
| Weight Increased |
10.3% |
| Vomiting |
7.0% |
| Weight Decreased |
6.3% |
| Type 2 Diabetes Mellitus |
5.7% |
| Tremor |
5.3% |
| Diabetes Mellitus |
4.7% |
| Drug Ineffective |
4.7% |
| Pancreatitis |
4.7% |
| Convulsion |
4.3% |
| Death |
4.0% |
| Urinary Tract Infection |
3.7% |
| Wound |
3.7% |
| Pneumonia |
3.3% |
| Suicidal Ideation |
3.3% |
| Syncope |
3.3% |
| Toxicity To Various Agents |
3.3% |
| Nausea |
3.0% |
| Pain |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
|
| Interacting |
| Hypertension |
18.7% |
| Hyperlipidaemia |
12.5% |
| Constipation |
6.2% |
| Convulsion |
6.2% |
| Gastrooesophageal Reflux Disease |
6.2% |
| Hypothyroidism |
6.2% |
| Psychotic Disorder |
6.2% |
| Type 2 Diabetes Mellitus |
6.2% |
| Mental Disorder |
5.2% |
| Adverse Event |
3.9% |
| Prophylaxis |
3.9% |
| Schizophrenia |
3.9% |
| Vitamin Supplementation |
2.6% |
| Adverse Drug Reaction |
2.3% |
| Cardiovascular Event Prophylaxis |
2.3% |
| Hyperglycaemia |
2.3% |
| Schizoaffective Disorder |
2.0% |
| Bipolar Disorder |
1.0% |
| Calcium Deficiency |
1.0% |
| Grand Mal Convulsion |
1.0% |
|
| Tremor |
57.1% |
| Drug Interaction |
14.3% |
| Drug Toxicity |
7.1% |
| Therapeutic Agent Toxicity |
7.1% |
| Insomnia |
3.6% |
| International Normalised Ratio Fluctuation |
3.6% |
| Lethargy |
3.6% |
| Somnolence |
3.6% |
|
